CSIMarket
 


Hologic Inc  (HOLX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

HOLX's Income from Cont. Operations Growth by Quarter and Year

Hologic Inc's Income from Cont. Operations results by quarter and year




HOLX Income from Cont. Operations (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter September - 456.00 1,302.00 327.00
III Quarter June - -40.50 228.40 268.40
II Quarter March - 218.50 455.70 619.90
I Quarter December 246.50 187.40 499.20 654.40
FY   246.50 821.40 2,485.30 1,869.70



HOLX Income from Cont. Operations first quarter 2024 Y/Y Growth Comment
Hologic Inc reported Income from Cont. Operations improvement of 31.54% year on year in the first quarter 2024, to $ 246.50 millions, this is lower than Hologic Inc's recent average Income from Cont. Operations surge of 137.56%.

According to the results reported in the first quarter 2024, Hologic Inc achieved the best Income from Cont. Operations growth in Medical Laboratories industry. While Hologic Inc' s Income from Cont. Operations rise of 31.54% ranks overall at the positon no. 209 in the first quarter 2024.




HOLX Income from Cont. Operations ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter September - -64.98 % 298.17 % -33.29 %
III Quarter June - - -14.9 % 94.63 %
II Quarter March - -52.05 % -26.49 % 543.72 %
I Quarter December 31.54 % -62.46 % -23.72 % 69.49 %
FY   - -66.95 % 32.93 % 68.37 %

Financial Statements
Hologic Inc's first quarter 2024 Income from Cont. Operations $ 246.50 millions HOLX's Income Statement
Hologic Inc's first quarter 2023 Income from Cont. Operations $ 187.40 millions Quarterly HOLX's Income Statement
New: More HOLX's historic Income from Cont. Operations Growth >>


HOLX Income from Cont. Operations (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter September - - 470.05 % 21.83 %
III Quarter June - - -49.88 % -56.7 %
II Quarter March - 16.6 % -8.71 % -5.27 %
I Quarter December -45.94 % -85.61 % 52.66 % 33.5 %
FY (Year on Year)   - -66.95 % 32.93 % 68.37 %




Income from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #10
Overall #209

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
1543.38 % 137.56 % -138.99 %
(Dec 26 2020)   (Dec 29 2018)
Income from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #10
Overall #209
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
1543.38 % 137.56 % -138.99 %
(Dec 26 2020)   (Dec 29 2018)

Income from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Hologic Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
509.02 % 54.62 % -100 %
(Apr 01 2017)  


HOLX's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2024 Hologic Inc reported fall in Income from Cont. Operations from the fourth quarter by -45.94% to $ 246.50 millions, from $ 456.00 millions declared in the previous quarter.

It's not huge issue, as Hologic Inc's Income from Cont. Operations frequently tend to slow in the I. Quarter Alfie  D. Wilson, a business advisor allocated in London told.

Within Medical Laboratories industry Hologic Inc achieved highest sequential Income from Cont. Operations growth. While Hologic Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 276.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #11
Overall #276
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #11
Overall #276
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
509.02 % 54.62 % -100 %
(Apr 01 2017)  


HOLX's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2024 Hologic Inc realized fall in Income from Cont. Operations sequentially by -45.94% to $ 246.50 millions, from $ 456.00 millions achived in the previous quarter.

But that's not huge issue, as I. Quarter Income from Cont. Operations always tend to dip in the I. Quarter.

Within Medical Laboratories industry Hologic Inc achieved highest sequential Income from Cont. Operations growth. While Hologic Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 276.


Hologic Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 30 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jul 01 2023)
12 Months Ending
(Apr 01 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ 880.50 $ 821.40 $ 1,667.40 $ 1,936.30 $ 2,173.50
Y / Y Income from Cont. Operations Growth (TTM) -59.49 % -66.95 % 10.4 % 24.9 % 26.77 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 80 # 456 # 967 # 1380 # 279
Seqeuential Income from Cont. Operations Change (TTM) 7.2 % -50.74 % -13.89 % -10.91 % -12.55 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 209 # 297 # 712 # 1245 # 1021




Cumulative Income from Cont. Operations growth Comment
Hologic Inc showed decline, but improvement compare to trailing twelve month Income from Cont. Operations decrease in Sep 30 2023. If the fiscal year would end in Dec 30 2023, Hologic Inc's annual Income from Cont. Operations fall would be -59.49% year on year to $881 millions.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 80, from total ranking in previous quarter at 456.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
1543.38 %
137.56 %
-138.99 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 0
Healthcare Sector # 4
Overall # 80

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1543.38 %
137.56 %
-138.99 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 10
S&P 500 # 209
Cumulative Income from Cont. Operations growth Comment
Hologic Inc showed decline, but improvement compare to trailing twelve month Income from Cont. Operations decrease in Sep 30 2023. If the fiscal year would end in Dec 30 2023, Hologic Inc's annual Income from Cont. Operations drop would be -59.49% year on year to $881 millions.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 80, from total ranking in previous quarter at 456.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
1543.38 %
137.56 %
-138.99 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 0
Healthcare Sector # 4
Overall # 80

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1543.38 %
137.56 %
-138.99 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 10
S&P 500 # 209




Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
HOLX's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for HOLX's Competitors
Income from Cont. Operations Growth for Hologic Inc's Suppliers
Income from Cont. Operations Growth for HOLX's Customers

You may also want to know
HOLX's Annual Growth Rates HOLX's Profitability Ratios HOLX's Asset Turnover Ratio HOLX's Dividend Growth
HOLX's Roe HOLX's Valuation Ratios HOLX's Financial Strength Ratios HOLX's Dividend Payout Ratio
HOLX's Roa HOLX's Inventory Turnover Ratio HOLX's Growth Rates HOLX's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Dec 30 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 30 2023
Abbott Laboratories54.31%$ 54.308 millions
Integer Holdings Corporation54.22%$ 54.225 millions
Lemaitre Vascular Inc 50.44%$ 50.435 millions
Encompass Health Corporation49.94%$ 49.941 millions
Msa Safety Incorporated48.40%$ 48.401 millions
Halozyme Therapeutics Inc 47.98%$ 47.981 millions
Cadre Holdings Inc 45.39%$ 45.386 millions
Chemed Corporation44.95%$ 44.952 millions
Viemed Healthcare Inc 42.62%$ 42.617 millions
Healthcare Services Group Inc 39.85%$ 39.848 millions
Ufp Technologies Inc 37.18%$ 37.178 millions
Catalyst Pharmaceuticals Inc 36.80%$ 36.799 millions
National Research Corporation33.38%$ 33.384 millions
West Pharmaceutical Services Inc 33.01%$ 33.010 millions
Hologic Inc31.54%$ 31.537 millions
Semler Scientific Inc 31.25%$ 31.250 millions
Takeda Pharmaceutical Company Limited30.34%$ 30.344 millions
Orasure Technologies Inc28.99%$ 28.987 millions
Conmed Corporation24.40%$ 24.402 millions
The Pennant Group Inc 22.84%$ 22.837 millions
Inmode Ltd 22.54%$ 22.535 millions
Option Care Health Inc 20.30%$ 20.299 millions
Vertex Pharmaceuticals Inc18.31%$ 18.305 millions
Avenue Therapeutics Inc 17.75%$ 17.748 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com